Ociperlimab (Synonyms: BGB-A1217) |
| Catalog No.GC69604 |
Ociperlimab es un anticuerpo humanizado IgG1 contra TIGIT. Ociperlimab se une con alta afinidad al dominio extracelular humano de TIGIT (KD = 0,135 nM). Ociperlimab bloquea la interacción entre TIGIT y sus ligandos PVR o PVR-L2. Ociperlimab puede ser utilizado en investigación del cáncer.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2342597-93-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Ociperlimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Ociperlimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *